196 related articles for article (PubMed ID: 6437007)
1. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
Verheijen JH; Rijken DC; Chang GT; Preston FE; Kluft C
Thromb Haemost; 1984 Jul; 51(3):396-7. PubMed ID: 6437007
[TBL] [Abstract][Full Text] [Related]
2. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.
Sue-Ling HM; Davies JA; Prentice CR; Verheijen JH; Kluft C
Thromb Haemost; 1985 Feb; 53(1):141-2. PubMed ID: 3873118
[TBL] [Abstract][Full Text] [Related]
3. [Anti-activator inhibitors of plasminogen].
Juhan-Vague I; Alessi MC; Aillaud MF
Ann Biol Clin (Paris); 1987; 45(2):202-6. PubMed ID: 3113299
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the occurrence of a fast-acting inhibitor for tissue-type plasminogen activator in human plasma.
Verheijen JH; Chang GT; Kluft C
Thromb Haemost; 1984 Jul; 51(3):392-5. PubMed ID: 6437006
[TBL] [Abstract][Full Text] [Related]
5. Advances in clinical fibrinolysis.
Hessel LW; Kluft C
Clin Haematol; 1986 May; 15(2):443-63. PubMed ID: 2942332
[TBL] [Abstract][Full Text] [Related]
6. Relationships between plasma insulin triglyceride, body mass index, and plasminogen activator inhibitor 1.
Juhan-Vague I; Vague P; Alessi MC; Badier C; Valadier J; Aillaud MF; Atlan C
Diabete Metab; 1987 Jul; 13(3 Pt 2):331-6. PubMed ID: 3115843
[TBL] [Abstract][Full Text] [Related]
7. Masking of fibrinolytic response to stimulation by an inhibitor of tissue-type plasminogen activator in plasma.
Brommer EJ; Verheijen JH; Chang GT; Rijken DC
Thromb Haemost; 1984 Oct; 52(2):154-6. PubMed ID: 6441302
[TBL] [Abstract][Full Text] [Related]
8. Bioimmunoassay (BIA) of tissue plasminogen activator (t-PA) and its specific inhibitor (t-PA/INH).
Mahmoud M; Gaffney PJ
Thromb Haemost; 1985 Jun; 53(3):356-9. PubMed ID: 3931284
[TBL] [Abstract][Full Text] [Related]
9. [Thromboembolic disease and anomalies of fibrinolysis].
Juhan-Vague I; Aillaud MF; Valadier J; Alessi MC; Serradimigni A
Ann Med Interne (Paris); 1986; 137(6):471-4. PubMed ID: 3101564
[TBL] [Abstract][Full Text] [Related]
10. Increased plasminogen activator inhibition levels in malignancy.
de Jong E; Knot EA; Piket D; Iburg AH; Rijken DC; Veenhof KH; Dooijewaard G; ten Cate JW
Thromb Haemost; 1987 Apr; 57(2):140-3. PubMed ID: 3110994
[TBL] [Abstract][Full Text] [Related]
11. [Inhibitors of fibrinolysis with special reference to anti-t-PA (inhibitor of the tissue plasminogen activator)].
Félez J; Rueda F
Sangre (Barc); 1985; 30(4-C):779-86. PubMed ID: 3937250
[No Abstract] [Full Text] [Related]
12. Fibrinolytic activity and protein C in preeclampsia.
Aznar J; Gilabert J; Estellés A; España F
Thromb Haemost; 1986 Jun; 55(3):314-7. PubMed ID: 3092388
[TBL] [Abstract][Full Text] [Related]
13. Increased PA-inhibitor levels in the postoperative period--no cause-effect relation with increased cortisol.
Aillaud MF; Juhan-Vague I; Alessi MC; Marecal M; Vinson MF; Arnaud C; Vague P; Collen D
Thromb Haemost; 1985 Aug; 54(2):466-8. PubMed ID: 2417352
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolytic system of cultured endothelial cells: regulation by plasminogen activator inhibitor.
Loskutoff DJ; Ny T; Sawdey M; Lawrence D
J Cell Biochem; 1986; 32(4):273-80. PubMed ID: 3100541
[TBL] [Abstract][Full Text] [Related]
15. Effect of caffein ingestion on plasma fibrinolytic potential.
Wojta J; Kirchheimer JC; Peska MG; Binder BR
Thromb Haemost; 1988 Apr; 59(2):337-8. PubMed ID: 3133816
[No Abstract] [Full Text] [Related]
16. Blood platelet plasminogen activator inhibitor: two different pools of endothelial cell type plasminogen activator inhibitor in human blood.
Sprengers ED; Akkerman JW; Jansen BG
Thromb Haemost; 1986 Jun; 55(3):325-9. PubMed ID: 3092389
[TBL] [Abstract][Full Text] [Related]
17. [Current developments in fibrinolytic therapy].
Rijken DC
Ned Tijdschr Geneeskd; 1985 Sep; 129(37):1768-72. PubMed ID: 3934567
[No Abstract] [Full Text] [Related]
18. Influence of beta-sitosterol on the fibrinolytic potential in rabbits.
Hoffmann A; Klöcking HP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):189-96. PubMed ID: 2459019
[TBL] [Abstract][Full Text] [Related]
19. [Poor fibrinolytic response to venous occlusion: defect of endothelial cells or plasma interference?].
Stalder M; Hauert J; Bachmann F
Schweiz Med Wochenschr; 1983 Oct; 113(40):1462-4. PubMed ID: 6606226
[TBL] [Abstract][Full Text] [Related]
20. Tissue-type plasminogen activator antigen and plasminogen activator inhibitor in diabetes mellitus.
Auwerx J; Bouillon R; Collen D; Geboers J
Arteriosclerosis; 1988; 8(1):68-72. PubMed ID: 2449156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
